These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14266988)

  • 1. THE IMPORTANCE OF PLASMA-FRACTION I ACCORDING TO COHN IN SURGICAL DISEASES.
    IMDAHL H; EGLI H
    Bibl Haematol; 1964; 19():151-5. PubMed ID: 14266988
    [No Abstract]   [Full Text] [Related]  

  • 2. [THE SUPPLY OF PERSONALLY PREPARED PLASMA FRACTIONS IN HEMOPHILIA A].
    GAERISCH F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1963; 81():148-55. PubMed ID: 14165084
    [No Abstract]   [Full Text] [Related]  

  • 3. THE IN VIVO LONGEVITY OF ANTIHAEMOPHILIC FACTOR (FACTOR VIII).
    ABILDGAARD CF; CORNET JA; FORT E; SCHULMAN I
    Br J Haematol; 1964 Apr; 10():225-37. PubMed ID: 14141621
    [No Abstract]   [Full Text] [Related]  

  • 4. THE USE OF PLASMA FRACTION I TO MAINTAIN HEMOSTASIS FOLLOWING AMPUTATION FOR HEMORRHAGIC CYST OF THE THIGH IN A SEVERE HEMOPHILIAC.
    LEWIS JH; COTTINGTON GM; BROWER TD
    J Bone Joint Surg Am; 1965 Mar; 47():333-9. PubMed ID: 14267874
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preparation of a human plasmatic fraction rich in factor VIII (antihemophilic A) and poor in fibrinogen].
    NIEMETZ J; WEILLAND C; SOULIER JP
    Nouv Rev Fr Hematol; 1961; 1():880-6. PubMed ID: 14479667
    [No Abstract]   [Full Text] [Related]  

  • 6. Modern aspects of the treatment of hemophilia.
    van CREVELD ; MOCHTAR IA
    Can Med Assoc J; 1962 Nov; 87(19):993-7. PubMed ID: 14023829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of classic hemophilia: the use of fibrinogen rich in factor VIII for hemorrhage and for surgery.
    MCMILLAN CW; DIAMOND LK; SURGENOR DM
    N Engl J Med; 1961 Aug; 265():277-83 concl. PubMed ID: 13774141
    [No Abstract]   [Full Text] [Related]  

  • 8. MODERN ASPECTS OF THE TREATMENT OF HEMOPHILIA. II.
    VAN CREVELD ; MOCHTAR IA; KOPPE JG
    Can Med Assoc J; 1963 Nov; 89(18):911-4. PubMed ID: 14052972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MODERN ASPECTS OF THE TREATMENT OF HEMOPHILIA. III.
    VANCREVELD S; MOCHTAR IA; KOPPE JG
    Can Med Assoc J; 1964 May; 90(22):1248-9. PubMed ID: 14158954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the intensity and quality of treatment and not only the factor VIII level influence global hemostasis in patients with hemophilia A?
    Berndtsson M; Zetterberg E; Holmström M; Mahmoud Hourani Soutari N; Mikovic D; Elezovic I; Antovic JP
    Thromb Res; 2016 Aug; 144():133-5. PubMed ID: 27331346
    [No Abstract]   [Full Text] [Related]  

  • 11. HAEMORRHAGIC DISEASES IN SURGERY. THE HAEMOSTATIC DEFECT IN HAEMOPHILIA AND ITS TEMPORARY CORRECTION.
    MACFARLANE RG
    Proc R Soc Med; 1965 Apr; 58(4):251-5. PubMed ID: 14263732
    [No Abstract]   [Full Text] [Related]  

  • 12. [The treatment of hemophilia A with a new antihemophilic fraction "AHF SRK (human)". Comparison with the antihemophilic globulin AHG SRK].
    Duckert F; Müller G; Meili EO
    Schweiz Med Wochenschr; 1971 Dec; 101(50):1831-8. PubMed ID: 5173501
    [No Abstract]   [Full Text] [Related]  

  • 13. [ON THE USE OF ANIMAL ANTIHEMOPHILIC GLOBULINS IN SEVERE OPERATIONS ON HEMOPHILIC PATIENTS].
    FONIO A; BACHMANN F
    Dtsch Med Wochenschr; 1964 Jan; 89():186-90. PubMed ID: 14117081
    [No Abstract]   [Full Text] [Related]  

  • 14. EXPERIENCES IN THE PREPARATION OF AHG CONCENTRATES FROM HUMAN PLASMA.
    POOL JG; HINK JH
    Bibl Haematol; 1964; 19():146-50. PubMed ID: 14266987
    [No Abstract]   [Full Text] [Related]  

  • 15. RECONSTITUTED HUMAN FIBRINOGEN IN THE TREATMENT OF HEMOPHILIA. REPORT OF A CASE.
    MARLETTE RH; GERHARD RC
    Oral Surg Oral Med Oral Pathol; 1964 May; 17():691-5. PubMed ID: 14131591
    [No Abstract]   [Full Text] [Related]  

  • 16. [Significance of the level of factor VIII in the blood during surgery on patients with hemophilia A].
    Rutberg RA; Andreev IuN
    Probl Gematol Pereliv Krovi; 1972 May; 17(5):30-4. PubMed ID: 5034489
    [No Abstract]   [Full Text] [Related]  

  • 17. [PRESERVATION OF ANTIHEMOPHILIC GLOBULIN IN PRESERVED BLOOD].
    RUTBERG RA; MALLER AR; ABDULLAEV GM
    Probl Gematol Pereliv Krovi; 1963 Sep; 8():19-23. PubMed ID: 14119758
    [No Abstract]   [Full Text] [Related]  

  • 18. Cryoprecipitate therapy in haemophilia.
    Forbes CD; Hunter J; Barr RD; Davidson JF; Short DW; McDonald GA; McNicol GP; Wallace J; Douglas AS
    Scott Med J; 1969 Jan; 14(1):1-9. PubMed ID: 5304824
    [No Abstract]   [Full Text] [Related]  

  • 19. [EXPERIMENTS CONCERNING FACTOR 8. LONGEVITY OF FACTOR 8 IN VIVO AND VITRO AND THE SUBFRACTIONATION OF FIBRINOGEN SAMPLES FROM 2 DONORS].
    MOCHTAR IA; KOPPE JG; STIBBE J
    Maandschr Kindergeneeskd; 1964 Jul; 32():440-5. PubMed ID: 14228685
    [No Abstract]   [Full Text] [Related]  

  • 20. Surgery in hemophilia A patients with factor VIII inhibitor: 10-year experience.
    Scharf R; Kucharski W; Nowak T
    World J Surg; 1996; 20(9):1171-81. PubMed ID: 8864078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.